Financhill
Back

Madrigal Pharmaceuticals Vs. IDEAYA Biosciences Industry Stock Comparison

Sell
40

MDGL
Madrigal Pharmaceuticals

Last Price:
208.42
Seasonality Move:
30.52%
Sell
10

IDYA
IDEAYA Biosciences

Last Price:
29.97
Seasonality Move:
8.04%
Sell
40
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $208.41. The Score for MDGL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
IDEAYA Biosciences (IDYA) is a Sell

Is IDEAYA Biosciences a Buy, Sell or Hold?

  • The current IDEAYA Biosciences [IDYA] share price is $29.97. The Score for IDYA is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • IDYA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $208.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.

IDYA Stock Price Chart

What is IDEAYA Biosciences's stock price today?

  • The IDEAYA Biosciences share price today is $29.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDYA is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.61 Sell
Relative Strength Index (14 RSI): 29.93 Sell
Chaikin Money Flow: 56748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (215.25 - 242.01) Sell
Bollinger Bands (100): (227.78 - 277.26) Sell

IDYA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 33.45 Sell
Chaikin Money Flow: 598622 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.36 - 37.46) Sell
Bollinger Bands (100): (34.51 - 40.93) Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 211.02 Sell
20-day SMA: 224.84 Sell
50-day SMA: 242.85 Sell
200-day SMA: 242.12 Sell
8-day EMA: 212.56 Sell
20-day EMA: 222.92 Sell
50-day EMA: 237.58 Sell
200-day EMA: 237.29 Sell

IDYA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.61 Sell
20-day SMA: 33.53 Sell
50-day SMA: 36.79 Sell
200-day SMA: 39.72 Sell
8-day EMA: 30.98 Sell
20-day EMA: 33.04 Sell
50-day EMA: 35.64 Sell
200-day EMA: 36.69 Sell

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.

IDEAYA Biosciences Earnings Growth & IDYA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.31 per share.

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

IDEAYA Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):